13G Filing: James E. Flynn and Mirna Therapeutics Inc. (MIRN)

Item 4.

Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)

Amount beneficially owned**:

Deerfield Management Company, L.P. – 850,143 shares

Deerfield Mgmt III, L.P. – 850,143 shares

Deerfield Private Design Fund
III, L.P. – 850,143 shares

James E. Flynn – 850,143 shares

(b)

Percent of class**:

Deerfield Management Company, L.P. – 5.22%

Deerfield Mgmt III, L.P. – 5.22%

Deerfield Private Design Fund III, L.P. – 5.22%

James E. Flynn – 5.22%

(c)

Number of shares as to which such person has**:

(i)

Sole power to vote or to direct the vote:

All Reporting Persons 0

(ii)

Shared power to vote or to direct the vote:

Deerfield
Management Company, L.P. – 850,143

Deerfield Mgmt III, L.P. – 850,143

Deerfield Private Design Fund III, L.P. – 850,143

James E. Flynn – 850,143

(iii)

Sole power to dispose or to direct the disposition of:

All Reporting Persons – 0

(iv)

Shared power to dispose or to direct the disposition
of:

Deerfield Management Company, L.P. – 850,143

Deerfield Mgmt III, L.P. – 850,143

Deerfield Private Design Fund III, L.P. –
850,143

James E. Flynn – 850,143


(j)	☐	A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);

(k)	☐	Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

Page 7 of 12 – SEC Filing